More people died following Pfizer’s COVID-19 vaccine vs. a placebo during clinical trial
12/10/2021 // Mary Villareal // Views

Nobody can truthfully claim that Pfizer's Wuhan coronavirus (COVID-19) vaccine has been proven by a clinical trial to save lives. Still, people are being pressured to receive the vaccine under threat of court-martial, loss of employment, denial of medical treatment and exclusion from normal life.

On Nov. 8, the Food and Drug Administration published a report updating the clinical trial results of Pfizer's mRNA-based COVID-19 vaccine. The trial included around 44,000 people over the age of 16, equally divided into two groups. One group received the vaccine and the other a placebo.

Page 23 of the report showed that over the course of the trial, there were a total of 38 deaths among participants: 21 in the vaccinated group and 17 in the placebo group. Because the number of deaths in the vaccinated group was not significantly less than the placebo group (but is, in fact, more than the placebo group), the vaccine failed to prove itself by the standard of all-cause mortality.

All-cause mortality standard

All-cause mortality is the number of deaths due to any cause in both the control and treated groups of a clinical trial. This is the most reliable clinical endpoint for the evaluation of a medical treatment that is supposed to reduce mortality because it is objective and properly accounts for unanticipated effects, which may offset the anticipated benefits of a treatment.

The National Academy of Sciences published a volume that explained the evaluative advantage of all-cause mortality with many lessons from the annals of medical history. A contributor to the volume, renowned anesthetist John P. Bunker, said: "When dealing with mortality as an endpoint of treatment, all-cause mortality is ignored at the peril of the investigators and the public."

Brighteon.TV

The burden of proving statistical significance is on the vaccine, not the placebo. The primary hypothesis of the clinical trial was that the vaccine would save lives, and for the hypothesis to be upheld, the death rate in the vaccinated group had to be significantly less than that of the placebo group – which did not happen in this case.

There is currently no scientific basis for retaining the hypothesis that the administration of the Pfizer COVID-19 vaccine could save lives.

However, there are reasons besides vaccination why the COVID death rate may be higher in one society than another, including population-age distributions, vaccinations and even access to therapeutics. The most obvious problem, however, is the reinforcing bias of the clinician, who knows whether or not the patient has been COVID-vaccinated. Among multiple comorbidities, the clinician might be more likely to attribute the death to COVID if he or she knows that the patient is not vaccinated.

If this happens, then the clinicians in populations with a higher vaccination rate would be less likely to attribute the deaths to COVID than the clinicians in populations with lower vaccination rates.

Pfizer's COVID-19 vaccine is still experimental

Because Pfizer's COVID-19 vaccine doesn't have a successful trial for all-cause mortality, it still remains experimental. (Related: Critics blasts FDA for full "approval" of Pfizer vaccine.)

None of the trials were designed to detect a reduction in any serious outcomes such as hospitalizations and deaths. While the vaccines are hailed to be the solution to the pandemic, clinical trials could not and did not prove that they can save lives. None of the vaccines studied were supported by concrete evidence to be able to interrupt the transmission of the virus.

Part of the reason for the lack of convincing results may be the numbers, because most people with symptomatic COVID-19 infections only experience mild symptoms, even for trials involving 30,000 or more patients.

"Hospitalizations and deaths from covid-19 are simply too uncommon in the population being studied for an effective vaccine to demonstrate statistically significant differences in a trial of 30,000 people. The same is true regarding whether it can save lives or prevent transmission. The trials are not designed to find out," said Peter Doshi, associate editor at the global healthcare knowledge publication, BMJ.

Read more news related to the coronavirus pandemic at Pandemic.news.

Sources include:

LifeSiteNews.com

FDA.gov

BMJ.com



Take Action:
Support Natural News by linking to this article from your website.
Permalink to this article:
Copy
Embed article link:
Copy
Reprinting this article:
Non-commercial use is permitted with credit to NaturalNews.com (including a clickable link).
Please contact us for more information.
Free Email Alerts
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.
App Store
Android App
eTrust Pro Certified

This site is part of the Natural News Network © 2022 All Rights Reserved. Privacy | Terms All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing International, LTD. is not responsible for content written by contributing authors. The information on this site is provided for educational and entertainment purposes only. It is not intended as a substitute for professional advice of any kind. Truth Publishing assumes no responsibility for the use or misuse of this material. Your use of this website indicates your agreement to these terms and those published here. All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.

This site uses cookies
Natural News uses cookies to improve your experience on our site. By using this site, you agree to our privacy policy.
Learn More
Close
Get 100% real, uncensored news delivered straight to your inbox
You can unsubscribe at any time. Your email privacy is completely protected.